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Abstract
DNA damage of exposed tumour tissue leading to cell death is one of the detrimental effects of ionising radiation that is exploited, with beneﬁcial consequences,
for radiotherapy. The pattern of the discrete energy depositions during passage of the ionising track of radiation deﬁnes the spatial distribution of lesions
induced in DNA with a fraction of the DNA damage sites containing clusters of lesions, formed over a few nanometres, against a background of endogenously
induced individual lesions. These clustered DNA damage sites, which may be considered as a signature of ionising radiation, underlie the deleterious biological
consequences of ionising radiation. The concepts developed rely in part on the fact that ionising radiation creates signiﬁcant levels of clustered DNA damage,
including complex double-strand breaks (DSB), to kill tumour cells as clustered damage sites are difﬁcult to repair. This reduced repairability of clustered DNA
damage using speciﬁc repair pathways is exploitable in radiotherapy for the treatment of cancer. We discuss some potential strategies to enhance radiosen-
sitivity by targeting the repair pathways of radiation-induced clustered damage and complex DNA DSB, through inhibition of speciﬁc proteins that are not
required in the repair pathways for endogenous damage. The variety and severity of DNA damage from ionising radiation is also inﬂuenced by the tumour
microenvironment, being especially sensitive to the oxygen status of the cells. For instance, nitric oxide is known to inﬂuence the types of damage induced by
radiation under hypoxic conditions. A potential strategy based on bioreductive activation of pro-drugs to release nitric oxide is discussed as an approach to
deliver nitric oxide to hypoxic tumours during radiotherapy. The ultimate aim of this review is to stimulate thinking on how knowledge of the complexity of
radiation-induced DNA damage may contribute to the development of adjuncts to radiotherapy.
 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
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Ionising radiation can be considered as a ‘two-edged
sword’ in that it may lead to genetic modiﬁcations in
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beneﬁt after radiotherapy. One of the ways in which ionis-
ing radiation works is through damaging the DNA of
exposed tumour tissue leading to cell death.
We are continually exposed to oxidative stress, with as
many as 50 000 lesions of DNA modiﬁcations [1] induced
daily in each cell through reactive oxygen species (ROS),
formed as a by-product of aerobic metabolism. Cells have
well-developed repair processes to deal with damage
induced through oxidative stress as it is vital that the
cellular responses are able to maintain genome integrity
and stability to minimise the onset of potential tumori-
genesis and the ageing process. The identiﬁcation of the
different types of lesion induced endogenously and the free
radical mechanisms of their formation have been described
in numerous reviews [2e4] and an excellent book by von
Sonntag [5]. Ionising radiation also results in DNA modiﬁ-
cations in each cell exposed at the fractionated doses
conventionally used in radiotherapy. The types of lesion
produced via exposure to ionising radiation are, in themain,ier Ltd. All rights reserved.
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instance, ionising radiation induces in mammalian cells
around 850 pyrimidine lesions, 450 purine lesions, 1000
single-strand breaks (SSB) and 20e40 double-strand breaks
(DSB)/cell/Gy with low linear energy transfer (LET) g-radi-
ation (Table 1 shows yields of major lesions induced by
radiation [3]). The spectrum of the types of damage and
their yields are similar when induced by ion particles as
used in hadron therapy (Table 1).
For a typical therapeutic dose of around 2 Gy/fraction of
sparsely ionising radiation, about 3000 DNA lesions are
produced per cell exposed, a level of damage far lower than
the level of up to 50 000 lesions produced daily through
ROS. A frequently asked question is why should a 2 Gy dose
of ionising radiation, which produces a lower burden of
radiation-induced DNA damage relative to the plethora of
damage induced daily through ROS, lead to signiﬁcant loss
of clonogenic survival of tumour cells.
In this review, we will address this question based on the
energy distribution events/ionisations in the radiation track
deﬁning the characteristic spatial distribution of damage
(clustering) and how knowledge of DNA damage may
contribute to the development of adjuncts to radiotherapy.Why Radiation Damage is More Effective
than Endogenous Damage at Killing Cells
As illustrated in Figure 1, the radiation track deposits
energy in the biomolecules of the cell during its passage.
The pattern of these discrete energy depositions during
passage of the ionising track causes chemical modiﬁcations
to the biomolecules and, as a consequence, deﬁnes the
spatial distribution of lesions induced. If we focus on DNA as
the major biomolecule of interest, a fraction of the DNA
damage sites induced by ionising radiation will have two or
more lesions formed within one or two helical turns of the
DNA, shown schematically in Figure 1. These sites induced
by a single radiation track are termed clustered damage
sites and also include DSB. Clustered damage sites may be
considered as a signature of ionising radiation in contrast
with isolated, endogenously induced lesions, which tend to
be homogeneously distributed. It is only over the last 10
years that radiation-induced clustered damage sites have
been detected in mammalian cells, with the yield of non-
DSB clusters being at least four to eight times that of
prompt DSB when induced by g-radiation [7e9].Table 1
The yield of major lesions induced by ionising radiations of different q
Radiation-induced lesions in cellular DNA N
g
5,6-thymine glycol (Tg) 5
5-(hydroxymethyl)-20-deoxyuridine 1
5-formyl-20-deoxyuridine 1
FapyG 2
8-oxo-7,8-dihydro-20-deoxyguanosine 1
Single-strand breaks 10With low LET radiation, about 70% of the energy depos-
ited induces isolated lesions, which add to the oxidative
burden of the cell [10,11]. More importantly, about 30% of
the energy deposited induces clustered damage sites of
varying structural and chemical complexity. For densely
ionising radiation [12], about 90% of the energy deposited
results in clustered damage sites including DSB. The
complexity of the clusters, reﬂecting the number of lesions
present, increases with the LET of the radiation (see Figure 1
for schematic representation of clustered damage contain-
ing two lesions). It is known that clustered damaged sites
including DSB, which are structurally and chemically com-
plex, have reduced reparability when comparedwith that of
individual lesions [13e15]. It is often overlooked that the
response to, and efﬁciency of, repair of DNA damage may
depend on the complexity of the DNA damage site and as
such should be seen as a different substrate during the
repair process. The importance of these substrates has
recently been highlighted in the reduced repair efﬁciency of
DNA lesions within a clustered damaged site or when
associated with a complex DSB [16e20]. It is the spatial
distribution of those lesions, when formed in clusters by
radiation, coupled with their reduced ability to be repaired
that contributes to more effective killing of tumour cells by
ionising radiation.Ionising Radiation-induced Double-strand
Breaks
Due to its cytotoxicity, the most deleterious lesion
induced by ionising radiation is thought to be the DSB, a
break in the phosphodiester backbone of both strands of the
DNA separated by about 10 base pairs or less [21,22]. As DSB
are thought to be the major radio-toxic damage, it is not
surprising that few, if any, DSB are induced endogenously
[23,24]. Both simple and complex DSB (Figure 1) are
induced by ionising radiation with 30 blocking ends, e.g. 30-
phosphate or 30-phosphoglycolate moieties [25,26], and
possess single-stranded overhangs of variable length,
whereas complex DSB have a high frequency of oxidised
base modiﬁcations and abasic (AP) sites directly adjacent of
the DSB ends [27e29]. The yield of DSB increases linearly
with radiation dose, starting from a dose of a few mGy [30].
In addition, the more relaxed DNA is (as in transcriptionally
active DNA) the DNA damage increases in yield and be-
comes more complex [31,32].uality (adapted from Cadet et al. [3])
umber/Gy/cell Number/Gy/cell
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Fig 1. Schematic of the types of DNA damage, ranging from single and clustered damage sites through to simple and complex double-strand
breaks (DSB), formed by passage of a single radiation track. Low linear energy transfer radiation induces lower concentrations of ionisation
events and consequently less complex DNA damage sites than high linear energy transfer. The coloured stars represent base or sugar lesions.
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pathways, namely non-homologous end joining (NHEJ) and
homologous recombination. Homologous recombination
provides greater repair ﬁdelity than NHEJ, the latter being
the major pathway to repair prompt DSB throughout all
phases of the cell cycle (reviewed in [33,34]). Evidence in-
dicates that the majority of DSB induced by low LET radia-
tion are rejoined within 30e60 min, whereas a small
fraction of DSB, generally <20%, are less readily repaired in
mammalian cells and some may persist for >24 h [35e40].
As the LET of the irradiation increases, so does the propor-
tion of breaks that are repaired slowly and it is thought that
the slower repairing DSB reﬂect the increasing proportion
that are complex.
NHEJ is the major pathway to repair DSB. It involves the
recruitment of Ku70/80 and DNA-PKcs to the DSB termini,
followed by processing of the DSB by the MRN complex
(Mre11, RAD50 and Nbs1), Artemis, PNKP and APLF, gap
ﬁlling by polymerases m and l and is completed by ligation
via Ligase IV, XRCC4 and XLF (reviewed in [41]). Ku70/80 is
recruited to all DSB, but DNA-PKcs is only involved in the
repair of the longer lived complex DSB [36,42]. Blocked 30
termini and, to a greater extent, base lesions and AP sites
close to the termini of DSB can drastically reduce the ligation
and repair of DSB [19,29]. The base excision repair (BER)
pathway (themajor pathway for the removal of base lesions)
is also compromised when removing base lesions close to
DSB termini [19], consistent with the observation that
complex DSB are rejoined before base lesions are removed
[29]. Any lesions present in a 50-overhang of a DSB may be
‘negated’ by trans-lesion synthesis, as shown by ‘negation’ of
an AP site before NHEJ takes place [43]. This process avoids
loss of DNA sequences, but may be mutagenic.
With the introduction of ion therapy with ions such
as 12C6þ, the consequences of complex DSB, which are
more difﬁcult to repair and require DNA-PKcs when
repaired by NHEJ, needs to be considered in terms of an
increased relative biological effectiveness of ion therapy
and a reduction in the effects of radio-resistant hypoxic
cells.Ionising Radiation-induced Non-double-
strand Break Clustered Damage
Non-DSB clustered damage sites containing two or more
lesions within one to two turns of the DNA helix (see
Figure 1) can be bistranded (lesions on both strands of the
DNA helix) or in tandem (two or more lesions adjacent on
the same strand of DNA). As with DSB, biophysical model-
ling conﬁrms that as the ionisation density of the radiation
increases, both the complexity and the yield of non-DSB
clustered damage increases [44].
Endogenously induced isolated lesions are repaired very
efﬁciently in cells by the BER pathway (reviewed in [45]).
The BER pathway is also the major pathway responsible for
the repair of non-DSB clustered DNA damage sites. It is now
well established that the efﬁciency of repair of lesions
within both bistranded and tandem clustered damage sites
is reduced compared with that for the repair of isolated
lesions (reviewed in [15]). The extent of the reduction in
repair depends on the types of lesion within the cluster, the
inter-lesion separation, the number of lesions within the
cluster (complexity) and the orientation of the lesions to
each other. For instance, a SSB (formed directly by ionising
radiation or via the action of an AP endonuclease or glyco-
sylase on an AP site or base lesion) or an AP site confers a
strong retardation on the removal of a nearby base lesion by
glycosylases [46,47] and a base lesion close to a SSB can
strongly impair the repair of the SSB [48,49].
Of importance is the ﬁnding that certain clustered
damage sites, especially those that are orientated 30 to each
other, have a greater dependence on the long-patch BER
pathway in contrast to isolated lesions, which are repaired
predominately by the short-patch repair pathway
[48,50,51]. In addition, some lesions induced by ionising
radiation, such as oxidised AP sites, cannot be repaired by
short-patch BER and have to rely on the long-patch BER
pathway. Use of the long-patch BER pathway in mammalian
cells will probably result in the formation of a DSB
compared with the short-patch pathway [52].
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clustered damage sites whereby a SSB retards the excision
of a base lesion until the SSB has been repaired
[48,49,53,54], thus limiting the formation of DSB. Further-
more, the excision of the ﬁrst base lesion in a clustered site
will prevent the excision of further base lesions [51]. This
hierarchy serves to extend the lifetime of the clustered
damaged site. For instance, the lifetime of lesions in a
clustered damage site may be up to eight times that of the
same lesions when in isolation [48]. A consequence of
increasing the lifetime of the lesions within a cluster is that
the chance of them encountering a replication fork before
their repair is increased. As a consequence, the enhanced
mutagenic potential of the lesions within the cluster in-
creases, conﬁrmed through the observation of elevated
mutation frequencies with a number of clustered damage
sites in bacteria [49,51,55,56]. In contrast, bistranded AP
sites are rapidly incised, despite being in close proximity, to
form DSB in vitro [49,50,57], in bacteria [49,58] and yeast
[59]. Interestingly, bistranded AP sites do not form DSB in
mammalian cells [60], but bistranded furans (obligate long-
patch BER substrates) do [61], suggesting that short-patch
BER of an AP site is preferred. Indeed clustered AP sites
have been shown to live for days in cells [62]. It was esti-
mated that 10% of non-DSB clustered lesions are converted
to DSB during processing [63] and if there are other lesions
in close proximity to these newly formed DSB, then com-
plex DSB would be formed [9,61].Replication-induced Double-strand Breaks
In addition to the formation of radiation-induced prompt
DSB, replication DSB are formed after ionising radiation (see
Figure 2 for schematic representations), detected as RAD51
foci at times >2e3 h [64,65]. It is thought that replication-
induced DSB, which are chemically distinct from prompt
DSB, are formed when an unrepaired non-DSB clustered
damage site meets a replication fork to produce a
replication-induced DSB [65,66], which requires homolo-
gous recombination for its repair [66e68]. The concept of
an extended lifetime of radiation-induced lesions when in
clusters is similar to that proposed to explain synthetic
lethality in BRCA-deﬁcient cells when PARP inhibition
causes SSB to persist longer and as a consequence theirFig 2. Schematic illustration of radiation-induced prompt and
replication-induced double-strand breaks. These two types of double-
strand break are chemically distinct.probability of encountering a replication fork is enhanced
[69,70].Radiosensitisation of Hypoxic Tumours
Revisited e A Role for Clustered DNA
Damage
The variety and severity of DNA damage from ionising
radiation is inﬂuenced by the tumour microenvironment. In
particular, the oxygen status of a tumour has a huge role to
play in local control after radiotherapy. Many tumours are
comprised of poorly oxygenated hypoxic regions that are
chemo- and radio-resistant [71] and patients displaying
highly hypoxic tumours have a much poorer outcome than
those with well-oxygenated tumours [72]. Mechanistically,
the radiosensitising effect of O2 can in part be explained
through its extremely rapid reaction, within a few milli-
seconds, with radiation-induced DNA radicals (Figure 3),
which ultimately lead to the products shown in Table 1.
However, the types of base damage and the yields of base
release arising through ionising radiation vary between
oxygenated and hypoxic cells [5]. Additionally, the forma-
tion of different types of lesion within clustered damage
sites may have consequences on the repair of the lesion
within the clusters as discussed above.
The difﬁculties of treating hypoxic tumours with radio-
therapy can be partially overcome by altering the cellular
microenvironment. Enhancing radiation-induced DNA
damage relies upon the presence or indeed absence (of a
radioprotector) of a free radical reactant exactly at the time
of radiotherapy. Chemical radiosensitisers, in particular
electron afﬁnic molecules like nitroaromatic compounds,
react and may conjugate with free radicals generated at
DNA bases [73] in a similar manner to O2, inducing strand
breaks (described in [74]) and modiﬁed base lesions
(Figure 3). However, early success with 2-nitroimidazoles
(e.g. misonidazole) had limited clinical use because of se-
vere neurotoxicity and the 5-nitroimidazole, nimorazole
[75], and the nitrotriazole, sanazole [76], are now the main
electron-afﬁnic compounds being assessed for clinical
radiosensitiser use.
Another hypoxic cell radiosensitiser that is gaining
renewed interest since ﬁrst being recognised as long ago as
60 years [77] is nitric oxide (NO). NO is a natural compound
produced in tissue by nitric oxide synthases, but it is also
amenable to drug delivery. Delivery of NO (or indeed any
radiosensitiser) to a solid tumour, speciﬁcally to the hypoxic
regions, is however a challenge.
Although the effect NO offers may in part be through
increasing tumour oxygenation (reviewed in [78]), it can
also inﬂuence the types of damage induced by radiation
under hypoxic conditions [79e81]. NO as a stable free
radical reacts rapidly with DNA radicals formed by ionising
radiation (kw 109 M1 s1) [79] (Figure 3). The presence of
NO in mammalian cells irradiated under hypoxia leads to
increased numbers of SSB and DSB [79,80] and this is
particularly evident hours after irradiation, when most
simple strand breaks would have been repaired [81,82].
Fig 3. Schematic showing the comparison of the pathways for reaction of hydroxyl radical adducts of DNA nucleobases with oxygen and the
hypoxic cell radiosensitisers, nitro-arenes and nitric oxide (NO). Whereas the products of reactions with oxygen and nitro-arenes are still free
radicals, only NO forms a non-radical product.
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reactions of DNA radicals with O2 when long-lived peroxyl
radicals are formed, which may induce the formation of SSB
through secondary free radical reactions (Figure 3). [83]. In
addition, NO reacts with DNA base radicals to form non-
radical modiﬁed bases (Figure 3). For example, 8-
azaguanine nucleotide, a cytotoxic triazole form of gua-
nine, has been identiﬁed in plasmid DNA irradiated in the
presence of NO [81]. These modiﬁed base lesions, especially
if present in a clustered damage site, may be difﬁcult to
repair by conventional mechanisms and as a consequence
may lead to replication fork collapse to give replication DSB
(Figure 2) and ultimately cell death, as shown by Folkes and
O’Neill [82].Ionising Radiation: A Double-edged Sword
The complexity of ionising radiation-induced DNA
damage underlies its deleterious biological consequences
and this property of ionising radiation is exploited in
radiotherapy for the treatment of cancer, including the
potential use of some adjuncts to enhance radiosensitivity
of hypoxic cells. These concepts rely in part on the fact that
fractionated doses of ionising radiation create signiﬁcant
levels of clustered DNA damage, including complex DSB, to
kill tumour cells, particularly as clustered damage sites are
difﬁcult for the cell to repair. Additionally, tumour cells are
often deﬁcient in the effective pathways required to repair
these types of damage, e.g. BRCA1 deﬁciency affecting the
homologous recombination pathway. However, the lower
doses of irradiation that are received by the normal tissues
have to be considered, as it is these cells that may not
receive a cytotoxic dose, but may have non-DSB clustered
damage induced. X-ray doses as low as 10e100 cGy havebeen seen to result in clusters of AP sites in primary human
ﬁbroblasts [84]. These poorly repaired clustered damage
sites may lead to mutations, chromosomal aberrations and,
ultimately, secondary cancers. The balance between steri-
lising tumour cells and sparing normal tissue is also a
crucial consideration in radiotherapy, especially as targeted
radiation delivery, e.g. intensity-modulated radiotherapy,
image-guided radiotherapy and ion therapy, gains in
prominence to enhance the curative effects in eradicating
cancer. Normal tissue close to tumour tissue will receive
higher doses from the above targeted radiation deliveries
than from present conventional radiation delivery and this
area is worthy of further research.Chemically Targeting ClusteredDNADamage
Sites as Adjuncts to Radiotherapy
The protein kinase ataxia-telangiectasia mutated (ATM)
plays a facilitating step in the repair of a subset (about 10%)
of radiation-induced complex DSB [14]. We have recently
shown that DNA-PKcs is recruited preferentially during the
repair of complex DSB and that retardation of phosphory-
lation of DNA-PKcs by an ATM inhibitor results in ‘slowing’
the release of not only DNA-PKcs but also Ku80 from com-
plex DSBs [36]. As a result, the lifetime of complex but not
simple DSB is extended by an ATM inhibitor, known to
enhance radiosensitivity.
Similarly, several radiation-induced non-DSB clustered
damage sites rely upon the long-patch BER pathway,
whereas most endogenously induced isolated lesions rely
upon short-patch BER. Thus, reducing the efﬁciency of the
long-patch BER pathway through an inhibitor may lead to
an increase in the lifetime of lesions within a cluster. As a
consequence, the persistence of the clustered damage, if in
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replication fork, leading to its collapse to result in a
replication-induced DSB. For instance, inhibition of FEN1, a
protein involved in long-patch BER, blocked LP-BER causing
enhancement of the cytotoxicity of the DNA-alkylating
agent Temozolomide in colon cancer cells [85].
From a better understanding of the spectrum of DNA
damage induced by radiation, it may be possible to target
the repair of radiation-induced clustered damage and
complex DNA DSB through inhibiting speciﬁc proteins that
are preferentially required for repair of these types of
damage but importantly do not interfere signiﬁcantly with
the repair of endogenous damage or simple DSB.
To enhance the radiosensitivity of hypoxic cells, agents
have previously been developed as donors or modulators of
NO, such as diazeniumdiolates (NONOates) [86,87], nitrite
[88], NO-donating non-steroidal anti-inﬂammatory drugs
[80], dinitroazetidines [89], insulin and electrical stimulus
[90] and cytokine activation of macrophages [91]. Pro-drugs
incorporating a ‘trigger-effector’ system are activated
through free radical reactions by cellular reductases in
hypoxic tissue, and were described by Denny et al. [92]. This
concept has recently been applied to the non-radiotherapy
based phase I study of TH-302 [93]. Bioreductive activation
of pro-drugs to release NO is an alternative approach to
speciﬁcally targeting hypoxia to ﬁx radiation-induced DNA
damage and a potential route [94] to deliver NO to hypoxic
tumours for radiotherapy.Conclusion
The aim of the review was to stimulate some concepts
whereby the knowledge on the spectrum of DNA damage
induced by radiation against the background plethora of
endogenously induced DNA damage may be used to
develop strategies to target speciﬁc types of damage that
utilise repair proteins not required in the repair of endog-
enous damage. The cellular microenvironment, which can
be altered through drug intervention, and the energy of the
ionising radiation, inﬂuence the type and abundance of
DNA damage arising. The ability of the cell to repair speciﬁc
and different lesions determines the ultimate fate of the cell
and it is the multitude of possible variations in DNA damage
complexity that, in part, inﬂuence radiation lethality.
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